{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:45:41Z","timestamp":1780368341124,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1347-5","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T09:02:58Z","timestamp":1562144578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4692-284X","authenticated-orcid":false,"given":"Khemchand Netaram","family":"Moorani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harnam Moolchand","family":"Hotchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasia Mohammad","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelesh Chander","family":"Lohana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanga Ram","family":"Veerwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"issue":"2","key":"1347_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ki.1978.23","volume":"13","author":"Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis","year":"1978","unstructured":"Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int. 1978;13(2):159\u201365.","journal-title":"Kidney Int"},{"issue":"4","key":"1347_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF01956754","volume":"152","author":"JH Ehrich","year":"1993","unstructured":"Ehrich JH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie. Eur J Pediatr. 1993;152(4):357\u201361.","journal-title":"Eur J Pediatr"},{"key":"1347_CR3","unstructured":"KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. Kidney Int Suppl. 2012;(2):139\u2013274."},{"issue":"1","key":"1347_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1681\/ASN.2012070646","volume":"24","author":"N Teeninga","year":"2013","unstructured":"Teeninga N, Kist-van Holthe JE, van Rijswijk N, de IN M, CJW H, FMJ W, Albert J, van der Heijden JA, et al. Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol. 2013;24(1):149\u201359.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1347_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2014.240","volume":"87","author":"A Sinha","year":"2015","unstructured":"Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, et al. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int. 2015;87(1):217\u201324.","journal-title":"Kidney Int"},{"issue":"1","key":"1347_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.2014.260","volume":"87","author":"N Yoshikawa","year":"2015","unstructured":"Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, et al. A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int. 2015;87(1):225\u201332.","journal-title":"Kidney Int"},{"key":"1347_CR7","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00467-017-3780-7","volume":"33","author":"MJ Kemper","year":"2018","unstructured":"Kemper MJ, Valentin L, Husen M. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options. Pediatr Nephrol. 2018;33:1641\u20139. \n                    https:\/\/doi.org\/10.1007\/s00467-017-3780-7\n                    \n                  .","journal-title":"Pediatr Nephrol"},{"key":"1347_CR8","doi-asserted-by":"crossref","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. 2015;(3):Cd001533.","DOI":"10.1002\/14651858.CD001533.pub5"},{"key":"1347_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00467-016-3458-6","volume":"32","author":"K Raja","year":"2017","unstructured":"Raja K, Parikh A, Webb H, Hothi D. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children. Pediatr Nephrol. 2017;32:99. \n                    https:\/\/doi.org\/10.1007\/s00467-016-3458-6\n                    \n                  .","journal-title":"Pediatr Nephrol"},{"key":"1347_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","volume":"93","author":"MP Gruppen","year":"2018","unstructured":"Gruppen MP, Bouts AH, Jansen-van der Weide MC, Markus MP, Zurowska A, Maternik M, et al. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. Kidney Int. 2018;93:510\u20138.","journal-title":"Kidney Int"},{"key":"1347_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004670000523","volume":"16","author":"K Latta","year":"2001","unstructured":"Latta K, von Schnakenburg C, Ehrich JH. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatric Nephrol. 2001;16:271\u201382.","journal-title":"Pediatric Nephrol"},{"issue":"10141","key":"1347_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","volume":"392","author":"Damien G Noone","year":"2018","unstructured":"Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet. 2018. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(18)30536-1\n                    \n                  .","journal-title":"The Lancet"},{"key":"1347_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00467-017-3746-9","volume":"33","author":"K Iijima","year":"2018","unstructured":"Iijima K, Sako M, Kamei K, Nozul K. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials. Pediatr Nephrol. 2018;33:1449\u201355. \n                    https:\/\/doi.org\/10.1007\/s00467-017-3746-9\n                    \n                  .","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"1347_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2016","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2016;12(2):332\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1347_CR15","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/S0140-6736(16)00272-5","volume":"387","author":"J Floege","year":"2016","unstructured":"Floege J, Amann K. Primary glomerulonephritides. Lancet. 2016;387:2036\u201348.","journal-title":"Lancet"},{"issue":"1","key":"1347_CR16","first-page":"10","volume":"34","author":"AR Sherali","year":"2010","unstructured":"Sherali AR, Moorani KN, Chishty SH. Response to Cyclosporin in children with primary focal segmental glomerulosclerosis. Pak Pediatr J. 2010;34(1):10\u20134.","journal-title":"Pak Pediatr J"},{"issue":"6","key":"1347_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.29271\/jcpsp.2018.06.436","volume":"28","author":"IA Bajeer","year":"2018","unstructured":"Bajeer IA, Khatri S, Tresa V, Hashmi S, Mubarak M, Lanewala AA. Histopathological Spectrum and short-term outcome of treatment with cyclophosphamide in relapsing steroid-sensitive nephrotic Syndrome. J Coll Physicians Surg Pak. 2018;28(6):436\u20139.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"1347_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00467-014-2903-7","volume":"30","author":"Andrea Pasini","year":"2014","unstructured":"Pasini A, Aceto G, Ammenti A, Ardissino G, Azzolina V, Bettinelli A et al.\u00a0Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality.\u00a0Pediatr Nephrol2015;\u00a030(1), 91-101.\u00a0\n                    https:\/\/doi.org\/10.1007\/s00467-014-2903-7\n                    \n                  .","journal-title":"Pediatric Nephrology"},{"key":"1347_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","volume":"43","author":"The Italian Society for Pediatric Nephrology","year":"2017","unstructured":"The Italian Society for Pediatric Nephrology. (SINePe) consensus document on the management of nephrotic syndrome in children: part I - diagnosis and treatment of the first episode and the first relapse. Italian J Pediatr. 2017;43:41. \n                    https:\/\/doi.org\/10.1186\/s13052-017-0356-x\n                    \n                  .","journal-title":"Italian J Pediatr"},{"key":"1347_CR20","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00467-017-3616-5","volume":"32","author":"AS Abeyagunawardena","year":"2017","unstructured":"Abeyagunawardena AS, Karunadasa U, Jayaweera H, Tennakoon S, Abeyagunawardena S. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2017;32:1363\u20137.","journal-title":"Pediatr Nephrol"},{"key":"1347_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13312-014-0419-7","volume":"51","author":"S Ekambaram","year":"2014","unstructured":"Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic Syndrome. Indian Pediatr. 2014;51:371\u20133.","journal-title":"Indian Pediatr"},{"key":"1347_CR22","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s11255-012-0241-x","volume":"45","author":"AT Elmas","year":"2013","unstructured":"Elmas AT, Tabel Y, Elmas ON. Long- and short-term efficacy of levamisole in children with steroid- sensitive nephrotic syndrome. Int Urol Nephrol. 2013;45:1047\u201355.","journal-title":"Int Urol Nephrol"},{"key":"1347_CR23","doi-asserted-by":"crossref","unstructured":"Liu Y, Yang R, Yang C, Dong S, Zhu Y, Zhao M et al. Cyclophosphamide versus cyclosporin A in steroid resistant nephrotic syndrome: a retrospective study with a mean 5-year follow up. J Intern Med Res 2018;46(11):4506-17","DOI":"10.1177\/0300060518782017"},{"key":"1347_CR24","doi-asserted-by":"crossref","unstructured":"Pravitsitthikul N, Willis NS, Hodson EM, Craig JC. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev. 2013;(10):CD002290.","DOI":"10.1002\/14651858.CD002290.pub4"},{"key":"1347_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00467-010-1717-5","volume":"26","author":"M Van Husen","year":"2011","unstructured":"Van Husen M, Kemper MJ. New therapies in steroid sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 2011;26:881\u201392.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"1347_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijpam.2017.03.002","volume":"4","author":"Khalid Alsaran","year":"2017","unstructured":"Alsaran K, Mirza K, Al-Talhi A, Al-Kanani E. Experience with second line drugs in frequently relapsing and steroid dependent childhood nephrotic syndrome in a large Saudi center. Inter J Pediatr Adolesc Med. 2017. \n                    https:\/\/doi.org\/10.1016\/j.ijpam.2017.03.002\n                    \n                  .","journal-title":"International Journal of Pediatrics and Adolescent Medicine"},{"issue":"1","key":"1347_CR27","doi-asserted-by":"publisher","first-page":"e11567","DOI":"10.5812\/ijp.11567","volume":"8","author":"J Li","year":"2018","unstructured":"Li J, Li Q, Lu J, Li Z. Immunosuppressive therapy in children with steroid-resistant nephrotic Syndrome. Iran J Pediatr. 2018;8(1):e11567. \n                    https:\/\/doi.org\/10.5812\/ijp.11567\n                    \n                  .","journal-title":"Iran J Pediatr"},{"issue":"10","key":"1347_CR28","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1681\/ASN.2012121200","volume":"24","author":"Jutta Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L, Tonshoff B, Hoyer P, Querfeld U. Mycophenolate mofetil versus cyclosporin a in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol. 24:1689\u201397.","journal-title":"Journal of the American Society of Nephrology"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1347-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1347-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1347-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T23:26:19Z","timestamp":1593645979000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1347-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1347-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"assertion":[{"value":"10 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was taken from The Kidney Centre Ethical Review Committee (TKC-ERC-Under the auspices of Dorab Patel Post Graduate Training & Research Centre) vide reference No. 62-NEPH-012018 (EXEMPTION) titled \u201cImmunosuppressive Therapy in Children with Difficult Nephrotic Syndrome at The Kidney Centre, Karachi, Pakistan\u201d. Consent to participate was not required from individual patients due to the retrospective nature of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent from individual patients is not required due to retrospective data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"239"}}